← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
76	TIAA CREF Investment Management New York	$45.3M	+$46.5M	6	0.04%	New
77	Thomaspartners Boston, Massachusetts	$43.3M	+$39.8M	1	1.7%	New
78	Brandywine Global Investment Management Philadelphia, Pennsylvania	$42.3M	+$43.5M	1	0.43%	New
79	Goldman Sachs New York	$42.3M	+$43.3M	8	0.02%	New
80	Fred Alger Management New York	$42M	+$43.9M	1	0.25%	New
81	RA Capital Management Boston, Massachusetts	$41.9M	+$46.8M	1	5.56%	New
82	Douglas C. Lane & Associates New York	$38.6M	+$39.6M	1	1.5%	New
83	KeyBank National Association Cleveland, Ohio	$38.5M	+$40M	3	0.14%	New
84	Russell Frank Company Seattle, Washington	$38M	+$39M	6	0.07%	New
85	Two Sigma Investments New York	$37.5M	+$38.6M	3	0.26%	New
86	Todd Asset Management Louisville, Kentucky	$37.4M	+$38.4M	1	1.22%	New
87	Baird Milwaukee, Wisconsin	$36.6M	+$37.6M	3	0.73%	New
88	BC Broadwood Capital New York	$35.7M	+$35.8M	1	8.12%	New
89	Mondrian Investment Partners London, United Kingdom	$35.5M	+$36.4M	1	0.54%	New
90	Bartlett & Co Cincinnati, Ohio	$35.4M	+$36.4M	1	1.95%	New
91	GGHC Gilder Gagnon Howe & Co New York	$35.2M	+$33.1M	1	0.66%	New
92	D.E. Shaw & Co New York	$35.1M	+$34.9M	4	0.07%	New
93	Natixis Advisors Boston, Massachusetts	$34M	+$35M	1	0.68%	New
94	Fifth Third Bancorp Cincinnati, Ohio	$33.7M	+$34.6M	4	0.36%	New
95	NPA Nichols & Pratt Advisers Boston, Massachusetts	$32.3M	+$33.2M	1	3.38%	New
96	Van Berkom & Associates Montreal, Quebec, Canada	$32.1M	+$33.6M	1	2.41%	New
97	Elliott Management New York	$32.1M	+$36.7M	1	0.62%	New
98	Bradley Foster & Sargent Hartford, Connecticut	$32M	+$32.9M	1	1.98%	New
99	Adage Capital Partners Boston, Massachusetts	$31.6M	+$33.8M	2	0.1%	New
100	Fort Washington Investment Advisors Cincinnati, Ohio	$31.5M	+$32.3M	1	0.72%	New